

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 5.72255997 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.50236870 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.50236870 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.50236870 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.50236870 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.50236870 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.50236870 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 5.46980443 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.09054403 |
| 10 | microglial cell activation (GO:0001774) | 4.98004447 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.85129558 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.80095642 |
| 13 | myeloid leukocyte mediated immunity (GO:0002444) | 4.63185676 |
| 14 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.61374032 |
| 15 | superoxide anion generation (GO:0042554) | 4.46355035 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.43187435 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.43187435 |
| 18 | macrophage activation (GO:0042116) | 4.39926082 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99402647 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 3.97258409 |
| 21 | detection of biotic stimulus (GO:0009595) | 3.92175006 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.82645090 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.80491161 |
| 24 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.70647370 |
| 25 | respiratory burst (GO:0045730) | 3.61960605 |
| 26 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.61489432 |
| 27 | response to host (GO:0075136) | 3.61489432 |
| 28 | response to host defenses (GO:0052200) | 3.61489432 |
| 29 | myeloid cell activation involved in immune response (GO:0002275) | 3.60365184 |
| 30 | multicellular organism reproduction (GO:0032504) | 3.57852786 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57569127 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55435458 |
| 33 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.49741665 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.47122506 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 3.43030446 |
| 36 | leukocyte aggregation (GO:0070486) | 3.32868822 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30614895 |
| 38 | acrosome reaction (GO:0007340) | 3.29584709 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27370782 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.27041948 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.26175318 |
| 42 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.25175773 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 3.24070811 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.23927112 |
| 45 | negative regulation of interleukin-17 production (GO:0032700) | 3.17165953 |
| 46 | positive regulation of mast cell degranulation (GO:0043306) | 3.16180367 |
| 47 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.16180367 |
| 48 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.15668015 |
| 49 | detection of other organism (GO:0098543) | 3.14789941 |
| 50 | response to peptidoglycan (GO:0032494) | 3.14558078 |
| 51 | regulation of regulated secretory pathway (GO:1903305) | 3.13842937 |
| 52 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.10678586 |
| 53 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.06689705 |
| 54 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.06304081 |
| 55 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.06304081 |
| 56 | dendritic cell chemotaxis (GO:0002407) | 3.04300809 |
| 57 | T-helper cell differentiation (GO:0042093) | 3.03506259 |
| 58 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.03506259 |
| 59 | activated T cell proliferation (GO:0050798) | 3.01523291 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01273833 |
| 61 | regulation of macrophage cytokine production (GO:0010935) | 3.00898280 |
| 62 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00353624 |
| 63 | detection of bacterium (GO:0016045) | 2.98781157 |
| 64 | daunorubicin metabolic process (GO:0044597) | 2.98683706 |
| 65 | polyketide metabolic process (GO:0030638) | 2.98683706 |
| 66 | doxorubicin metabolic process (GO:0044598) | 2.98683706 |
| 67 | neutrophil activation (GO:0042119) | 2.98410261 |
| 68 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.95084927 |
| 69 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.95084927 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90320143 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 2.89704164 |
| 72 | positive regulation of regulated secretory pathway (GO:1903307) | 2.89493115 |
| 73 | positive regulation of macrophage cytokine production (GO:0060907) | 2.87025942 |
| 74 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.85154586 |
| 75 | energy homeostasis (GO:0097009) | 2.84848077 |
| 76 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.82757256 |
| 77 | negative regulation of mast cell activation (GO:0033004) | 2.82581309 |
| 78 | regulation of interleukin-8 secretion (GO:2000482) | 2.82283662 |
| 79 | cellular response to interleukin-15 (GO:0071350) | 2.81473526 |
| 80 | hypotonic response (GO:0006971) | 2.80937169 |
| 81 | axonemal dynein complex assembly (GO:0070286) | 2.79260293 |
| 82 | presynaptic membrane assembly (GO:0097105) | 2.76669114 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76102079 |
| 84 | positive regulation of leukocyte degranulation (GO:0043302) | 2.75882316 |
| 85 | G-protein coupled receptor internalization (GO:0002031) | 2.74457557 |
| 86 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.74112924 |
| 87 | negative regulation of growth of symbiont in host (GO:0044130) | 2.73918283 |
| 88 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.73918283 |
| 89 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.73918283 |
| 90 | regulation of growth of symbiont in host (GO:0044126) | 2.73918283 |
| 91 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.73318068 |
| 92 | leukocyte degranulation (GO:0043299) | 2.72701204 |
| 93 | dendritic cell migration (GO:0036336) | 2.72267010 |
| 94 | neutrophil chemotaxis (GO:0030593) | 2.71099126 |
| 95 | sperm motility (GO:0030317) | 2.68495826 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67745872 |
| 97 | regulation of beta-amyloid formation (GO:1902003) | 2.67128214 |
| 98 | negative regulation of interleukin-8 production (GO:0032717) | 2.66389194 |
| 99 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.66076397 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65948774 |
| 101 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.65900478 |
| 102 | negative regulation of B cell mediated immunity (GO:0002713) | 2.65900478 |
| 103 | myeloid leukocyte activation (GO:0002274) | 2.65539413 |
| 104 | eosinophil migration (GO:0072677) | 2.65353768 |
| 105 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.64983825 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.64728548 |
| 107 | neutrophil migration (GO:1990266) | 2.64457881 |
| 108 | protein K11-linked deubiquitination (GO:0035871) | 2.64062983 |
| 109 | negative regulation of interleukin-6 production (GO:0032715) | 2.64058828 |
| 110 | I-kappaB phosphorylation (GO:0007252) | 2.63177892 |
| 111 | startle response (GO:0001964) | 2.62523513 |
| 112 | regulation of hypersensitivity (GO:0002883) | 2.61970913 |
| 113 | negative regulation of type 2 immune response (GO:0002829) | 2.61939457 |
| 114 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60647647 |
| 115 | nucleotide transmembrane transport (GO:1901679) | 2.59617539 |
| 116 | positive regulation of B cell differentiation (GO:0045579) | 2.57583334 |
| 117 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.56314469 |
| 118 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.56314469 |
| 119 | T cell differentiation involved in immune response (GO:0002292) | 2.56314469 |
| 120 | regulation of activation of Janus kinase activity (GO:0010533) | 2.56023471 |
| 121 | regulation of cellular amide metabolic process (GO:0034248) | 2.55562935 |
| 122 | defense response to protozoan (GO:0042832) | 2.55276734 |
| 123 | epithelial cilium movement (GO:0003351) | 2.54163455 |
| 124 | positive regulation of lymphocyte migration (GO:2000403) | 2.54136456 |
| 125 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.53592928 |
| 126 | presynaptic membrane organization (GO:0097090) | 2.53500243 |
| 127 | cornea development in camera-type eye (GO:0061303) | 2.51119304 |
| 128 | granulocyte activation (GO:0036230) | 2.50996498 |
| 129 | neutrophil activation involved in immune response (GO:0002283) | 2.50430976 |
| 130 | eosinophil chemotaxis (GO:0048245) | 2.50305681 |
| 131 | positive regulation of T cell migration (GO:2000406) | 2.46891177 |
| 132 | reproduction (GO:0000003) | 2.46597957 |
| 133 | glucosamine-containing compound catabolic process (GO:1901072) | 2.46437516 |
| 134 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.46375648 |
| 135 | interferon-gamma production (GO:0032609) | 2.46167210 |
| 136 | centriole assembly (GO:0098534) | 2.45245620 |
| 137 | motile cilium assembly (GO:0044458) | 2.44067067 |
| 138 | negative regulation of T cell mediated immunity (GO:0002710) | 2.42045893 |
| 139 | developmental pigmentation (GO:0048066) | 2.41838963 |
| 140 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.38393743 |
| 141 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.38298489 |
| 142 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.37836272 |
| 143 | monocyte chemotaxis (GO:0002548) | 2.37580228 |
| 144 | microtubule depolymerization (GO:0007019) | 2.36315484 |
| 145 | amine catabolic process (GO:0009310) | 2.33818712 |
| 146 | cellular biogenic amine catabolic process (GO:0042402) | 2.33818712 |
| 147 | adenosine metabolic process (GO:0046085) | 2.32182665 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.32119958 |
| 149 | T cell activation involved in immune response (GO:0002286) | 2.31481311 |
| 150 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.29379156 |
| 151 | regulation of mast cell activation (GO:0033003) | 2.28842364 |
| 152 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.28615358 |
| 153 | regulation of germinal center formation (GO:0002634) | 2.28007071 |
| 154 | cilium movement (GO:0003341) | 2.27620227 |
| 155 | regulation of cellular extravasation (GO:0002691) | 2.25870773 |
| 156 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.25738325 |
| 157 | NAD biosynthetic process (GO:0009435) | 2.25710075 |
| 158 | dentate gyrus development (GO:0021542) | 2.25221769 |
| 159 | cellular response to type I interferon (GO:0071357) | 2.23694998 |
| 160 | type I interferon signaling pathway (GO:0060337) | 2.23694998 |
| 161 | sympathetic nervous system development (GO:0048485) | 2.23228669 |
| 162 | response to host immune response (GO:0052572) | 2.23067912 |
| 163 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.23067912 |
| 164 | superoxide metabolic process (GO:0006801) | 2.22672334 |
| 165 | ceramide catabolic process (GO:0046514) | 2.22284434 |
| 166 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.22256838 |
| 167 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.21537952 |
| 168 | response to type I interferon (GO:0034340) | 2.21288074 |
| 169 | detection of external biotic stimulus (GO:0098581) | 2.21161018 |
| 170 | limb bud formation (GO:0060174) | 2.20975682 |
| 171 | regulation of T cell chemotaxis (GO:0010819) | 2.20200567 |
| 172 | positive regulation of T cell chemotaxis (GO:0010820) | 2.20200567 |
| 173 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.19796353 |
| 174 | opioid receptor signaling pathway (GO:0038003) | 2.19453520 |
| 175 | regulation of antigen processing and presentation (GO:0002577) | 2.17567581 |
| 176 | myeloid dendritic cell activation (GO:0001773) | 2.17361732 |
| 177 | cell wall macromolecule catabolic process (GO:0016998) | 2.17135553 |
| 178 | cell wall macromolecule metabolic process (GO:0044036) | 2.17135553 |
| 179 | positive regulation of antigen processing and presentation (GO:0002579) | 2.16501677 |
| 180 | extracellular negative regulation of signal transduction (GO:1900116) | 2.16285494 |
| 181 | extracellular regulation of signal transduction (GO:1900115) | 2.16285494 |
| 182 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.16273082 |
| 183 | response to muramyl dipeptide (GO:0032495) | 2.15994966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.50693327 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.48203918 |
| 3 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13932296 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99830699 |
| 5 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.98493251 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95280388 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.74861454 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.61827284 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.52806900 |
| 10 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.52723023 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.52592769 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48249537 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34678094 |
| 14 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.30315613 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.27195187 |
| 16 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.21339739 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.20062989 |
| 18 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.14117617 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13790452 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08787227 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07377518 |
| 22 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.06995900 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05377584 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04188988 |
| 25 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.99761606 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.96190175 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94563345 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93998656 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85123932 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.84340402 |
| 31 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.83537110 |
| 32 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.80172772 |
| 33 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.79938003 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79784599 |
| 35 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.77182938 |
| 36 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.76990283 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76662184 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74825302 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72717516 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72346267 |
| 41 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.70700188 |
| 42 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.70601448 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68055884 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66982762 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65380910 |
| 46 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.65116236 |
| 47 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.64418707 |
| 48 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.64166706 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60782283 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60509985 |
| 51 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.57421869 |
| 52 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.56722473 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56347940 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55972756 |
| 55 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.55862201 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54577396 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53496297 |
| 58 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.51963844 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51950900 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51791657 |
| 61 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.51266508 |
| 62 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.47614093 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47447296 |
| 64 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.45690952 |
| 65 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.44268992 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42061750 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40665535 |
| 68 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.40234862 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40179057 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40084671 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39642501 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.38800542 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38773283 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38560301 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38225685 |
| 76 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.36966504 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36234328 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36158940 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36017444 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35597697 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35347814 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34620336 |
| 83 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.34321895 |
| 84 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.34040807 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33794961 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32385720 |
| 87 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.32364267 |
| 88 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.31944428 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.31610687 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.31358483 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28743521 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28689645 |
| 93 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.27472733 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26709180 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25503476 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24976912 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24432170 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24218883 |
| 99 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24169869 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23465732 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 1.22157288 |
| 102 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21464911 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21254214 |
| 104 | MAF_26560356_Chip-Seq_TH1_Human | 1.20374755 |
| 105 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19798256 |
| 106 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.18866458 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18249679 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17981286 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15645109 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12721836 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12721836 |
| 112 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12559264 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11626600 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11545070 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11386606 |
| 116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10338473 |
| 117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10258803 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09755598 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09662487 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 1.09587144 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09141587 |
| 122 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09063191 |
| 123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08789356 |
| 124 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08548911 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08462014 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07743026 |
| 127 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07282261 |
| 128 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06609320 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06256859 |
| 130 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06252448 |
| 131 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05615852 |
| 132 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03567452 |
| 133 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.02687098 |
| 134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02644572 |
| 135 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02022191 |
| 136 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01837680 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01760741 |
| 138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01676006 |
| 139 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01311082 |
| 140 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01073697 |
| 141 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00652162 |
| 142 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00435787 |
| 143 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00202758 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99817884 |
| 145 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99723206 |
| 146 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.99698507 |
| 147 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98737360 |
| 148 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98586464 |
| 149 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98278231 |
| 150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98191458 |
| 151 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95325382 |
| 152 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95045793 |
| 153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94873135 |
| 154 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.90071463 |
| 155 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89714398 |
| 156 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89677091 |
| 157 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87955097 |
| 158 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.86344215 |
| 159 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86176854 |
| 160 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85389122 |
| 161 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85352410 |
| 162 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84538809 |
| 163 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.83870318 |
| 164 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81688793 |
| 165 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.81539785 |
| 166 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80426257 |
| 167 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79686725 |
| 168 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79430588 |
| 169 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78711498 |
| 170 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75700874 |
| 171 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.74856807 |
| 172 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74830646 |
| 173 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72933566 |
| 174 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72933566 |
| 175 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.70540867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.42462873 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.41861436 |
| 3 | MP0001188_hyperpigmentation | 3.23973026 |
| 4 | MP0004381_abnormal_hair_follicle | 3.08980343 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.06010761 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.91639693 |
| 7 | MP0003724_increased_susceptibility_to | 2.86190811 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.84861383 |
| 9 | MP0002277_abnormal_respiratory_mucosa | 2.50403027 |
| 10 | MP0000566_synostosis | 2.44761616 |
| 11 | MP0005409_darkened_coat_color | 2.44157449 |
| 12 | MP0003828_pulmonary_edema | 2.42899304 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.38345944 |
| 14 | MP0003690_abnormal_glial_cell | 2.33776942 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.30827847 |
| 16 | MP0009785_altered_susceptibility_to | 2.26866928 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.23820937 |
| 18 | MP0005671_abnormal_response_to | 2.20150157 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.13004100 |
| 20 | MP0003941_abnormal_skin_development | 2.06702518 |
| 21 | MP0005387_immune_system_phenotype | 2.02193187 |
| 22 | MP0001790_abnormal_immune_system | 2.02193187 |
| 23 | MP0000015_abnormal_ear_pigmentation | 1.99614367 |
| 24 | MP0005410_abnormal_fertilization | 1.96300632 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 1.93201428 |
| 26 | MP0002132_abnormal_respiratory_system | 1.89184124 |
| 27 | MP0003436_decreased_susceptibility_to | 1.88421366 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.86263778 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.82703669 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.80876864 |
| 31 | MP0009697_abnormal_copulation | 1.79346469 |
| 32 | MP0003136_yellow_coat_color | 1.74849159 |
| 33 | MP0002419_abnormal_innate_immunity | 1.74345720 |
| 34 | MP0000604_amyloidosis | 1.74335587 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.74136841 |
| 36 | MP0003329_amyloid_beta_deposits | 1.71819873 |
| 37 | MP0004883_abnormal_blood_vessel | 1.66942871 |
| 38 | MP0005171_absent_coat_pigmentation | 1.64702303 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.63606043 |
| 40 | MP0009278_abnormal_bone_marrow | 1.62266894 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.60668288 |
| 42 | MP0005025_abnormal_response_to | 1.59348874 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.58418457 |
| 44 | MP0001984_abnormal_olfaction | 1.58370549 |
| 45 | MP0009764_decreased_sensitivity_to | 1.54599777 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.52327120 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.51603824 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.51603824 |
| 49 | MP0003075_altered_response_to | 1.50457254 |
| 50 | MP0005164_abnormal_response_to | 1.49090636 |
| 51 | MP0001800_abnormal_humoral_immune | 1.48808726 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.48573156 |
| 53 | MP0000920_abnormal_myelination | 1.48378807 |
| 54 | MP0001346_abnormal_lacrimal_gland | 1.48365130 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.43387879 |
| 56 | MP0002254_reproductive_system_inflammat | 1.43233106 |
| 57 | MP0002723_abnormal_immune_serum | 1.42578976 |
| 58 | MP0002009_preneoplasia | 1.42256835 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.40334747 |
| 60 | MP0001851_eye_inflammation | 1.39136440 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.34465874 |
| 62 | MP0001819_abnormal_immune_cell | 1.34295014 |
| 63 | MP0000516_abnormal_urinary_system | 1.33868504 |
| 64 | MP0005367_renal/urinary_system_phenotyp | 1.33868504 |
| 65 | MP0002163_abnormal_gland_morphology | 1.33108142 |
| 66 | MP0000685_abnormal_immune_system | 1.31882393 |
| 67 | MP0001873_stomach_inflammation | 1.31072450 |
| 68 | MP0002102_abnormal_ear_morphology | 1.29560940 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.29272300 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 1.28953102 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.28520390 |
| 72 | MP0004947_skin_inflammation | 1.26300494 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.26199565 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.25579569 |
| 75 | MP0002735_abnormal_chemical_nociception | 1.24128537 |
| 76 | MP0005451_abnormal_body_composition | 1.23745947 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.14425067 |
| 78 | MP0002933_joint_inflammation | 1.13792919 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.10502675 |
| 80 | MP0004510_myositis | 1.07280699 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.06120047 |
| 82 | MP0003787_abnormal_imprinting | 1.05808708 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.05770477 |
| 84 | MP0004130_abnormal_muscle_cell | 1.05203436 |
| 85 | MP0008874_decreased_physiological_sensi | 1.05022465 |
| 86 | MP0000579_abnormal_nail_morphology | 1.04777777 |
| 87 | MP0002405_respiratory_system_inflammati | 1.03673299 |
| 88 | MP0002722_abnormal_immune_system | 1.01186918 |
| 89 | MP0000689_abnormal_spleen_morphology | 1.01118779 |
| 90 | MP0004484_altered_response_of | 1.00980075 |
| 91 | MP0009046_muscle_twitch | 0.99811121 |
| 92 | MP0002006_tumorigenesis | 0.99345509 |
| 93 | MP0008789_abnormal_olfactory_epithelium | 0.98819918 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.98615552 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.97598961 |
| 96 | MP0008469_abnormal_protein_level | 0.97397891 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.96059347 |
| 98 | MP0004742_abnormal_vestibular_system | 0.94931285 |
| 99 | MP0004859_abnormal_synaptic_plasticity | 0.93305201 |
| 100 | MP0010155_abnormal_intestine_physiology | 0.92970574 |
| 101 | MP0002429_abnormal_blood_cell | 0.92704528 |
| 102 | MP0009379_abnormal_foot_pigmentation | 0.91771444 |
| 103 | MP0001486_abnormal_startle_reflex | 0.89849796 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.89536940 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.89366589 |
| 106 | MP0006082_CNS_inflammation | 0.89303399 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88377998 |
| 108 | MP0003635_abnormal_synaptic_transmissio | 0.88297203 |
| 109 | MP0000858_altered_metastatic_potential | 0.88154579 |
| 110 | MP0005166_decreased_susceptibility_to | 0.88154534 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.87991266 |
| 112 | MP0000678_abnormal_parathyroid_gland | 0.87763451 |
| 113 | MP0004270_analgesia | 0.87616488 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.87464309 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.86569824 |
| 116 | MP0002638_abnormal_pupillary_reflex | 0.86365173 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.85851422 |
| 118 | MP0001186_pigmentation_phenotype | 0.85847562 |
| 119 | MP0000716_abnormal_immune_system | 0.85618731 |
| 120 | MP0002736_abnormal_nociception_after | 0.85507027 |
| 121 | MP0005310_abnormal_salivary_gland | 0.84778161 |
| 122 | MP0002098_abnormal_vibrissa_morphology | 0.84746079 |
| 123 | MP0002064_seizures | 0.84521162 |
| 124 | MP0003866_abnormal_defecation | 0.84373292 |
| 125 | MP0000538_abnormal_urinary_bladder | 0.83702949 |
| 126 | MP0003879_abnormal_hair_cell | 0.83433785 |
| 127 | MP0003633_abnormal_nervous_system | 0.83344742 |
| 128 | MP0003632_abnormal_nervous_system | 0.82551555 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.82239345 |
| 130 | MP0003045_fibrosis | 0.81771637 |
| 131 | MP0002938_white_spotting | 0.80789774 |
| 132 | MP0005388_respiratory_system_phenotype | 0.80645095 |
| 133 | MP0002133_abnormal_respiratory_system | 0.80645095 |
| 134 | MP0001853_heart_inflammation | 0.79579613 |
| 135 | MP0008995_early_reproductive_senescence | 0.79054323 |
| 136 | MP0008260_abnormal_autophagy | 0.77314919 |
| 137 | MP0001502_abnormal_circadian_rhythm | 0.76201002 |
| 138 | MP0001501_abnormal_sleep_pattern | 0.75238621 |
| 139 | MP0003091_abnormal_cell_migration | 0.74177650 |
| 140 | MP0003880_abnormal_central_pattern | 0.74108044 |
| 141 | MP0003448_altered_tumor_morphology | 0.73661642 |
| 142 | MP0000026_abnormal_inner_ear | 0.71740524 |
| 143 | MP0003631_nervous_system_phenotype | 0.71679341 |
| 144 | MP0005647_abnormal_sex_gland | 0.71230766 |
| 145 | MP0008004_abnormal_stomach_pH | 0.69479183 |
| 146 | MP0001968_abnormal_touch/_nociception | 0.69108076 |
| 147 | MP0002398_abnormal_bone_marrow | 0.68742618 |
| 148 | MP0005499_abnormal_olfactory_system | 0.68598606 |
| 149 | MP0005394_taste/olfaction_phenotype | 0.68598606 |
| 150 | MP0008877_abnormal_DNA_methylation | 0.65978581 |
| 151 | MP0009745_abnormal_behavioral_response | 0.64138784 |
| 152 | MP0005535_abnormal_body_temperature | 0.63234357 |
| 153 | MP0002063_abnormal_learning/memory/cond | 0.62833589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.61201863 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.21526452 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 4.21526452 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.15023830 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.65499793 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39642570 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.34228943 |
| 8 | Optic neuritis (HP:0100653) | 3.34228943 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.24845158 |
| 10 | Renal cortical cysts (HP:0000803) | 3.24605616 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.23920532 |
| 12 | Amyloidosis (HP:0011034) | 3.21736925 |
| 13 | Aplasia cutis congenita (HP:0001057) | 3.17566971 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.17528212 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.17528212 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.17528212 |
| 17 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.16107082 |
| 18 | Chromsome breakage (HP:0040012) | 3.09280290 |
| 19 | Tubulointerstitial nephritis (HP:0001970) | 3.02767583 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 2.97461919 |
| 21 | Abnormal ciliary motility (HP:0012262) | 2.93762560 |
| 22 | Eczematoid dermatitis (HP:0000976) | 2.93638829 |
| 23 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.89624762 |
| 24 | Slow saccadic eye movements (HP:0000514) | 2.87654513 |
| 25 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.86214097 |
| 26 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.86214097 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.84625439 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81407876 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81407876 |
| 30 | Urticaria (HP:0001025) | 2.80369011 |
| 31 | Alveolar cell carcinoma (HP:0006519) | 2.72392493 |
| 32 | Myositis (HP:0100614) | 2.72024871 |
| 33 | Spontaneous hematomas (HP:0007420) | 2.70868799 |
| 34 | Prostate neoplasm (HP:0100787) | 2.69487102 |
| 35 | Parakeratosis (HP:0001036) | 2.67074165 |
| 36 | Orchitis (HP:0100796) | 2.65208213 |
| 37 | Hemoptysis (HP:0002105) | 2.64524860 |
| 38 | Peritonitis (HP:0002586) | 2.63219917 |
| 39 | Joint hemorrhage (HP:0005261) | 2.63218166 |
| 40 | Chest pain (HP:0100749) | 2.62493492 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.60706771 |
| 42 | Papilledema (HP:0001085) | 2.59272018 |
| 43 | Chronic hepatic failure (HP:0100626) | 2.58531091 |
| 44 | White forelock (HP:0002211) | 2.58255936 |
| 45 | Hypothermia (HP:0002045) | 2.58241297 |
| 46 | Increased IgM level (HP:0003496) | 2.58187513 |
| 47 | Episodic fever (HP:0001954) | 2.55164011 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.54710831 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54198889 |
| 50 | Patchy hypopigmentation of hair (HP:0011365) | 2.51674225 |
| 51 | Cellulitis (HP:0100658) | 2.51147813 |
| 52 | Pulmonary embolism (HP:0002204) | 2.50484584 |
| 53 | Abnormality of the renal cortex (HP:0011035) | 2.49493593 |
| 54 | Febrile seizures (HP:0002373) | 2.46971126 |
| 55 | Dry hair (HP:0011359) | 2.41815362 |
| 56 | Chronic diarrhea (HP:0002028) | 2.41402132 |
| 57 | Abnormality of incisor morphology (HP:0011063) | 2.40544953 |
| 58 | Abnormal hair whorl (HP:0010721) | 2.36445132 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.34572096 |
| 60 | True hermaphroditism (HP:0010459) | 2.34432200 |
| 61 | Osteomalacia (HP:0002749) | 2.34190450 |
| 62 | Abnormality of the renal medulla (HP:0100957) | 2.32172194 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.30521415 |
| 64 | Disinhibition (HP:0000734) | 2.29734091 |
| 65 | Thrombocytosis (HP:0001894) | 2.29248177 |
| 66 | Duplicated collecting system (HP:0000081) | 2.29097234 |
| 67 | Recurrent skin infections (HP:0001581) | 2.28069887 |
| 68 | Gingivitis (HP:0000230) | 2.27570750 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 2.24597525 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.23692899 |
| 71 | Obstructive lung disease (HP:0006536) | 2.23692899 |
| 72 | Nephronophthisis (HP:0000090) | 2.23294448 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.23076085 |
| 74 | Postural instability (HP:0002172) | 2.22621924 |
| 75 | Epistaxis (HP:0000421) | 2.21757128 |
| 76 | Stomatitis (HP:0010280) | 2.20445114 |
| 77 | Difficulty running (HP:0009046) | 2.19431711 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.19189323 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.17958677 |
| 80 | Submucous cleft hard palate (HP:0000176) | 2.17812245 |
| 81 | Clubbing of toes (HP:0100760) | 2.17172368 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.14818282 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.14289948 |
| 84 | Prolonged partial thromboplastin time (HP:0003645) | 2.14084899 |
| 85 | Loss of speech (HP:0002371) | 2.12878152 |
| 86 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.12820154 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12264802 |
| 88 | Meningitis (HP:0001287) | 2.11622586 |
| 89 | Fair hair (HP:0002286) | 2.11117891 |
| 90 | Osteomyelitis (HP:0002754) | 2.09796751 |
| 91 | Ankle clonus (HP:0011448) | 2.09555082 |
| 92 | Diplopia (HP:0000651) | 2.08099761 |
| 93 | Abnormality of binocular vision (HP:0011514) | 2.08099761 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08059286 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 2.08004561 |
| 96 | Absent eyebrow (HP:0002223) | 2.06808726 |
| 97 | Vertigo (HP:0002321) | 2.04267829 |
| 98 | Congenital hepatic fibrosis (HP:0002612) | 2.04139177 |
| 99 | Abnormality of the nasal septum (HP:0000419) | 2.03906738 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 2.03313371 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 2.02404630 |
| 102 | Medial flaring of the eyebrow (HP:0010747) | 2.00983267 |
| 103 | Decreased central vision (HP:0007663) | 2.00145937 |
| 104 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99685764 |
| 105 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99685764 |
| 106 | Abnormality of DNA repair (HP:0003254) | 1.99519626 |
| 107 | Abnormality of the prostate (HP:0008775) | 1.99488079 |
| 108 | Leukocytosis (HP:0001974) | 1.98778998 |
| 109 | Scanning speech (HP:0002168) | 1.98202981 |
| 110 | Recurrent sinusitis (HP:0011108) | 1.96686012 |
| 111 | Pancreatic fibrosis (HP:0100732) | 1.96474111 |
| 112 | Lip pit (HP:0100267) | 1.96111005 |
| 113 | Gangrene (HP:0100758) | 1.95966854 |
| 114 | Keratoconjunctivitis (HP:0001096) | 1.94682447 |
| 115 | Hip dysplasia (HP:0001385) | 1.94458523 |
| 116 | Ocular albinism (HP:0001107) | 1.93337988 |
| 117 | Increased IgE level (HP:0003212) | 1.93310355 |
| 118 | Keratitis (HP:0000491) | 1.92787585 |
| 119 | Ectropion (HP:0000656) | 1.92287909 |
| 120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91767323 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 1.91603200 |
| 122 | Hypochromic anemia (HP:0001931) | 1.91380244 |
| 123 | Cheilitis (HP:0100825) | 1.91240549 |
| 124 | Gingival bleeding (HP:0000225) | 1.91024098 |
| 125 | Rhinitis (HP:0012384) | 1.90472962 |
| 126 | Encephalitis (HP:0002383) | 1.89065720 |
| 127 | Vasculitis (HP:0002633) | 1.88997157 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.88690051 |
| 129 | Keratoconjunctivitis sicca (HP:0001097) | 1.88099344 |
| 130 | Abnormality of the endocardium (HP:0004306) | 1.88007953 |
| 131 | T lymphocytopenia (HP:0005403) | 1.87761679 |
| 132 | Sepsis (HP:0100806) | 1.87748426 |
| 133 | Papillary thyroid carcinoma (HP:0002895) | 1.86733286 |
| 134 | Action tremor (HP:0002345) | 1.85872704 |
| 135 | Anorexia (HP:0002039) | 1.85494834 |
| 136 | Menstrual irregularities (HP:0000858) | 1.85134983 |
| 137 | Spastic gait (HP:0002064) | 1.85043286 |
| 138 | Abnormality of the corticospinal tract (HP:0002492) | 1.84873952 |
| 139 | Skin ulcer (HP:0200042) | 1.82698567 |
| 140 | Hypoplasia of the fovea (HP:0007750) | 1.80516728 |
| 141 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.80516728 |
| 142 | Anhidrosis (HP:0000970) | 1.80464845 |
| 143 | Agitation (HP:0000713) | 1.79433156 |
| 144 | Stomach cancer (HP:0012126) | 1.79346674 |
| 145 | Lower limb muscle weakness (HP:0007340) | 1.78793418 |
| 146 | Resting tremor (HP:0002322) | 1.77936227 |
| 147 | Conical tooth (HP:0000698) | 1.77695109 |
| 148 | Median cleft lip (HP:0000161) | 1.76931501 |
| 149 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76733695 |
| 150 | Apathy (HP:0000741) | 1.76450175 |
| 151 | Global brain atrophy (HP:0002283) | 1.75310707 |
| 152 | Abnormality of T cell number (HP:0011839) | 1.75263058 |
| 153 | Visual hallucinations (HP:0002367) | 1.75072317 |
| 154 | Diminished motivation (HP:0000745) | 1.74826403 |
| 155 | Tubulointerstitial abnormality (HP:0001969) | 1.74785763 |
| 156 | Thick nail (HP:0001805) | 1.74701981 |
| 157 | Inflammation of the large intestine (HP:0002037) | 1.74382685 |
| 158 | Optic nerve hypoplasia (HP:0000609) | 1.72918955 |
| 159 | Panhypogammaglobulinemia (HP:0003139) | 1.72280077 |
| 160 | Reduced antithrombin III activity (HP:0001976) | 1.71363059 |
| 161 | Recurrent lower respiratory tract infections (HP:0002783) | 1.66764539 |
| 162 | Glomerulopathy (HP:0100820) | 1.65326475 |
| 163 | Postaxial foot polydactyly (HP:0001830) | 1.64013124 |
| 164 | Prolonged bleeding time (HP:0003010) | 1.62152518 |
| 165 | Preaxial hand polydactyly (HP:0001177) | 1.61643250 |
| 166 | Periodontitis (HP:0000704) | 1.60888223 |
| 167 | Blue irides (HP:0000635) | 1.60600849 |
| 168 | Pancreatic cysts (HP:0001737) | 1.59406454 |
| 169 | Thyroiditis (HP:0100646) | 1.57618107 |
| 170 | Arterial thrombosis (HP:0004420) | 1.57448927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.35661392 |
| 2 | IRAK3 | 3.23631279 |
| 3 | IRAK4 | 3.16166956 |
| 4 | MAP3K14 | 2.97196997 |
| 5 | ZAK | 2.95350018 |
| 6 | TXK | 2.86260920 |
| 7 | INSRR | 2.60754652 |
| 8 | MAP2K3 | 2.60431188 |
| 9 | BMPR1B | 2.37400885 |
| 10 | SIK3 | 2.31383438 |
| 11 | MAP3K6 | 2.15964407 |
| 12 | FRK | 2.13230074 |
| 13 | MAP3K2 | 1.99201432 |
| 14 | IKBKE | 1.89656496 |
| 15 | STK16 | 1.79811078 |
| 16 | EIF2AK2 | 1.75136842 |
| 17 | FGR | 1.72846253 |
| 18 | KSR2 | 1.71620012 |
| 19 | BMPR2 | 1.65368574 |
| 20 | ERN1 | 1.63600259 |
| 21 | CDK3 | 1.63207203 |
| 22 | TNIK | 1.60459241 |
| 23 | MAP3K3 | 1.59318041 |
| 24 | TEC | 1.58828354 |
| 25 | IRAK1 | 1.58185339 |
| 26 | NUAK1 | 1.57076278 |
| 27 | GRK6 | 1.54197157 |
| 28 | MAP3K13 | 1.53162146 |
| 29 | YES1 | 1.49859983 |
| 30 | MAP3K12 | 1.48937327 |
| 31 | IKBKB | 1.40808549 |
| 32 | MARK2 | 1.40617773 |
| 33 | BLK | 1.40094213 |
| 34 | ERBB3 | 1.39216626 |
| 35 | MAP2K4 | 1.38630223 |
| 36 | ACVR1B | 1.37278954 |
| 37 | CAMKK2 | 1.35724223 |
| 38 | NEK6 | 1.33751612 |
| 39 | IRAK2 | 1.33150968 |
| 40 | ADRBK2 | 1.32316805 |
| 41 | GRK7 | 1.31115161 |
| 42 | MAP2K7 | 1.31007560 |
| 43 | JAK2 | 1.30460281 |
| 44 | MAP3K1 | 1.29233329 |
| 45 | TAOK1 | 1.28710653 |
| 46 | GRK1 | 1.27538803 |
| 47 | EPHA3 | 1.26942071 |
| 48 | MUSK | 1.25893905 |
| 49 | JAK3 | 1.23966879 |
| 50 | SGK2 | 1.21260830 |
| 51 | MAPK15 | 1.18258291 |
| 52 | MKNK2 | 1.16962290 |
| 53 | KSR1 | 1.15877940 |
| 54 | PIK3CG | 1.10819581 |
| 55 | CHUK | 1.07712601 |
| 56 | MAP3K11 | 1.03452338 |
| 57 | AKT3 | 1.03379491 |
| 58 | TGFBR2 | 1.02630718 |
| 59 | WNK1 | 1.02389394 |
| 60 | BTK | 0.99637581 |
| 61 | TIE1 | 0.98717420 |
| 62 | STK11 | 0.97640055 |
| 63 | PINK1 | 0.95336189 |
| 64 | MKNK1 | 0.95038031 |
| 65 | DAPK2 | 0.91536360 |
| 66 | MAPK13 | 0.90085238 |
| 67 | MAP4K1 | 0.89435906 |
| 68 | STK38 | 0.89134686 |
| 69 | KIT | 0.89021909 |
| 70 | TAOK3 | 0.87832614 |
| 71 | JAK1 | 0.87465106 |
| 72 | MAP3K5 | 0.87443431 |
| 73 | PKN1 | 0.87373076 |
| 74 | PRPF4B | 0.84675682 |
| 75 | MATK | 0.83371378 |
| 76 | CSF1R | 0.83127431 |
| 77 | CAMKK1 | 0.82307130 |
| 78 | NLK | 0.81994174 |
| 79 | EPHB1 | 0.79110065 |
| 80 | FGFR3 | 0.79039005 |
| 81 | SRPK1 | 0.77373779 |
| 82 | PDK1 | 0.76915214 |
| 83 | RAF1 | 0.76577818 |
| 84 | STK24 | 0.75662151 |
| 85 | TRPM7 | 0.75068612 |
| 86 | TYK2 | 0.74353065 |
| 87 | CDK8 | 0.74069495 |
| 88 | PIM2 | 0.73909001 |
| 89 | MARK3 | 0.73334264 |
| 90 | TNK2 | 0.73307215 |
| 91 | PDPK1 | 0.72387629 |
| 92 | TBK1 | 0.72218647 |
| 93 | PRKD2 | 0.72082849 |
| 94 | UHMK1 | 0.70139887 |
| 95 | LYN | 0.70046445 |
| 96 | PRKCE | 0.68970070 |
| 97 | SGK494 | 0.68200582 |
| 98 | SGK223 | 0.68200582 |
| 99 | PTK2B | 0.66568839 |
| 100 | LCK | 0.66064413 |
| 101 | RET | 0.65936064 |
| 102 | FYN | 0.62980311 |
| 103 | SYK | 0.62849914 |
| 104 | DYRK1B | 0.61997134 |
| 105 | PLK4 | 0.61538050 |
| 106 | ZAP70 | 0.61195187 |
| 107 | HCK | 0.60761461 |
| 108 | CAMK1G | 0.60610993 |
| 109 | MAPK7 | 0.60201977 |
| 110 | SGK3 | 0.60134229 |
| 111 | MAP3K7 | 0.60083157 |
| 112 | PRKCQ | 0.59555978 |
| 113 | VRK1 | 0.59268200 |
| 114 | MAP3K9 | 0.58503348 |
| 115 | TAOK2 | 0.58102196 |
| 116 | FES | 0.56801258 |
| 117 | BRD4 | 0.56751526 |
| 118 | CDK6 | 0.56177127 |
| 119 | CSK | 0.55548506 |
| 120 | MAPK12 | 0.54999147 |
| 121 | SIK2 | 0.52909012 |
| 122 | PDGFRB | 0.52378267 |
| 123 | NEK9 | 0.52153203 |
| 124 | HIPK2 | 0.50356027 |
| 125 | MAPKAPK5 | 0.49969099 |
| 126 | FGFR2 | 0.48926398 |
| 127 | CAMK1D | 0.48622543 |
| 128 | NTRK2 | 0.47243005 |
| 129 | MOS | 0.47180103 |
| 130 | RIPK1 | 0.45830367 |
| 131 | RIPK4 | 0.44217809 |
| 132 | CAMK4 | 0.43290606 |
| 133 | STK38L | 0.42833873 |
| 134 | PRKCZ | 0.42706595 |
| 135 | TESK1 | 0.42407077 |
| 136 | RPS6KC1 | 0.42173585 |
| 137 | RPS6KL1 | 0.42173585 |
| 138 | CLK1 | 0.42100774 |
| 139 | CDK19 | 0.41242280 |
| 140 | NTRK3 | 0.40049976 |
| 141 | PRKCD | 0.39928094 |
| 142 | MAPK4 | 0.39673483 |
| 143 | MAP2K6 | 0.39275608 |
| 144 | PRKG1 | 0.38413322 |
| 145 | MYLK | 0.37502008 |
| 146 | RPS6KB1 | 0.36457355 |
| 147 | MARK1 | 0.36387883 |
| 148 | ABL1 | 0.34688171 |
| 149 | SGK1 | 0.34279105 |
| 150 | ADRBK1 | 0.33598334 |
| 151 | PIM1 | 0.33575244 |
| 152 | DYRK1A | 0.32682510 |
| 153 | EPHB2 | 0.32010006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65027889 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.60439657 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.47265134 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.30014221 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26427329 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.25361337 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.20217351 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09061493 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97569918 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.93315497 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.87756107 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.82398551 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81812170 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81022436 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80970507 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.78734622 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.77481520 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64193366 |
| 19 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.60475732 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60330849 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54640274 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50970604 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50945781 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.47541224 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.41133662 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40829702 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40519088 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38209534 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.37928148 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35725363 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35075812 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.34664925 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33094282 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33068250 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.29776357 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29045311 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27824516 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27185427 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24461642 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24270703 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.22361012 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.21430733 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.20457356 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20048128 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18465515 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.18407966 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17781882 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.12756797 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.11479817 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10428828 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08813654 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08577259 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07731475 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07408302 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06846741 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05847201 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04767766 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04556878 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03340012 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02034827 |
| 61 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01391068 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01157109 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00759486 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00723170 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 1.00429204 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99893699 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99546644 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.95443115 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95304233 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94988174 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94895127 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93395480 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93201346 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92832927 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91487815 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88963530 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87083191 |
| 78 | Morphine addiction_Homo sapiens_hsa05032 | 0.86160422 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85860200 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84893811 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84291537 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.84244943 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84021056 |
| 84 | Influenza A_Homo sapiens_hsa05164 | 0.83805596 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.82926476 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82463134 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82307726 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81835804 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81739874 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80979363 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80039928 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79950191 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79470611 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79415739 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78410287 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.76420488 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74697329 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73713537 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.73361030 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71842571 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70916542 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70591237 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69497473 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69482613 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69214487 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68232836 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.68189623 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67975969 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66964217 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.66925504 |
| 111 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66718043 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66420846 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65286232 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63789543 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63204784 |
| 116 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63169409 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62102111 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61606009 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61560287 |
| 120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61248681 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.60627148 |
| 122 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60172511 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60140656 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59818177 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58929962 |
| 126 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58617146 |
| 127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58373684 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57480411 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57398619 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.56267448 |
| 131 | Legionellosis_Homo sapiens_hsa05134 | 0.56175209 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53313183 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53041040 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51884718 |
| 135 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51606962 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50379047 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.50045325 |
| 138 | Homologous recombination_Homo sapiens_hsa03440 | 0.49836161 |
| 139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49701939 |
| 140 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48455765 |
| 141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44917785 |
| 142 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43613893 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41619458 |
| 144 | Renin secretion_Homo sapiens_hsa04924 | 0.40816299 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40371159 |
| 146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39469248 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.38705664 |
| 148 | Hepatitis B_Homo sapiens_hsa05161 | 0.37744962 |
| 149 | Apoptosis_Homo sapiens_hsa04210 | 0.37030747 |
| 150 | Axon guidance_Homo sapiens_hsa04360 | 0.36322503 |
| 151 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35617415 |
| 152 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35522348 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32677490 |
| 154 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31266296 |

